Author Index

A

  • Abdel-Khalek, Ehab Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Abd Elmaqsood, Sayed Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Abozeid, Fatma Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Al Arman, Mohammed Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Aleraky, Shymaa Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Askar, Marwa Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]

B

  • Beait, Khaled Mohamed The Endoscopic Ultrasound Evaluation of Pancreatic Cystic Lesions [8.1, Issue 1, 2024, Pages 23-28]

E

  • El-Desoky, Abd- Elmohsen Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Elgamal, Salah Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Elkady, Mostafa Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]
  • El-Saadany, Mohamed Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • El-Saadany, Mohammed The Endoscopic Ultrasound Evaluation of Pancreatic Cystic Lesions [8.1, Issue 1, 2024, Pages 23-28]

G

  • Ghoneem, Elsayed The Endoscopic Ultrasound Evaluation of Pancreatic Cystic Lesions [8.1, Issue 1, 2024, Pages 23-28]

H

  • Habeeb, Maha The Endoscopic Ultrasound Evaluation of Pancreatic Cystic Lesions [8.1, Issue 1, 2024, Pages 23-28]

M

  • Menessy, Ayman Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Mohsen, Mohammed Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]

O

  • Omar, Maha Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]

R

  • Roshdy, Noha Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]

S

  • Saif Elnaser, Mounir Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]
  • Shabana, Hany Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Shabana, Hany Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]